Rosenbaum Nils A MD - Phoenix, Arizona 85012

Rosenbaum Nils A MD is categorized under Doctors in Phoenix, AZ .

Business Name: Rosenbaum Nils A MD
Contact Person: Nils Rosenbaum
Address: 3030 North Central Avenue # 1407, Phoenix, Arizona 85012
Phone Number: (602) 235-9155
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Patel Mariela MD - Phoenix, AZ 85012
Gunn Thomas Lee MD - Phoenix, AZ 85012
Kallmeyer Ian J MD - Phoenix, AZ 85012
Remchuk Stacey L MD - Phoenix, AZ 85012
Nichols Joe L MD - Phoenix, AZ 85012
Nordlie William C MD - Phoenix, AZ 85012
Irei Michael Y MD - Phoenix, AZ 85012
Martin Bosco C MD - Phoenix, AZ 85012
Gualtieri Ralph MD - Phoenix, AZ 85012
Gellert George MD - Phoenix, AZ 85012
Morris Gregory S MD - Phoenix, AZ 85012
Dupuy Michael J MD - Phoenix, AZ 85012
Wilkinson Elizabeth MD - Phoenix, AZ 85012
Oliverius Stanley J MD - Phoenix, AZ 85012
Ando Kerry J MD - Phoenix, AZ 85012
Kross Joe MD - Phoenix, AZ 85012
Streetman Mary MD - Phoenix, AZ 85012
Batra Shelly DO - Phoenix, AZ 85012
Morshedian Kourosh K MD - Phoenix, AZ 85012
Patel Nina MD - Phoenix, AZ 85012

The company Rosenbaum Nils A MD provides B2C services in the form of Doctors from its single location in Arizona. 1 to 4 employees work for Rosenbaum Nils A MD, and the business now earns $500.000 to $999.999 per annum.

Rosenbaum Nils A MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Rosenbaum Nils A MD, please call Nils Rosenbaum with the phone number (602) 235-9155 or visit its single location at 3030 North Central Avenue # 1407 in Phoenix, Arizona 85012.

The location of the single location can also be found using the coordinates 33.481621,-112.073833. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.